2024-03-05 |
2024-03-04 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
840
-0.5%
16,01
13.448
USD
|
840
-0.5%
|
16,01
|
13.448
USD
|
|
2024-03-05 |
2024-03-04 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
1.217
-0.5%
16,01
19.484
USD
|
1.217
-0.5%
|
16,01
|
19.484
USD
|
|
2024-03-05 |
2024-03-01 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
1.679
-1.0%
16,03
26.909
USD
|
1.679
-1.0%
|
16,03
|
26.909
USD
|
|
2024-03-05 |
2024-03-01 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
2.107
-0.8%
16,03
33.769
USD
|
2.107
-0.8%
|
16,03
|
33.769
USD
|
|
2024-02-29 |
2024-02-28 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
2.303
-0.9%
16,14
37.177
USD
|
2.303
-0.9%
|
16,14
|
37.177
USD
|
|
2024-02-29 |
2024-02-28 |
V
Verkauf
|
Leonard Frank X
EVP, Pres., Novocure Oncology
Führungsperson
|
2.078
-1.3%
16,14
33.545
USD
|
2.078
-1.3%
|
16,14
|
33.545
USD
|
|
2023-11-08 |
2023-11-07 |
GV
Geplanter Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
382
-0.3%
12,65
4.832
USD
|
382
-0.3%
|
12,65
|
4.832
USD
|
|
2023-09-05 |
2023-09-01 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
294
-0.1%
21,82
6.414
USD
|
294
-0.1%
|
21,82
|
6.414
USD
|
|
2023-09-05 |
2023-09-01 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
273
-0.2%
21,82
5.956
USD
|
273
-0.2%
|
21,82
|
5.956
USD
|
|
2023-09-05 |
2023-09-01 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
883
-0.9%
21,82
19.265
USD
|
883
-0.9%
|
21,82
|
19.265
USD
|
|
2023-08-04 |
2023-08-02 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
1.144
-1.1%
30,25
34.607
USD
|
1.144
-1.1%
|
30,25
|
34.607
USD
|
|
2023-03-07 |
2023-03-07 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
2.315
-4.1%
75,59
174.999
USD
|
2.315
-4.1%
|
75,59
|
174.999
USD
|
|
2023-03-07 |
2023-03-07 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
6.003
-9.6%
75,00
450.206
USD
|
6.003
-9.6%
|
75,00
|
450.206
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
20.415
-8.9%
76,16
1.554.794
USD
|
20.415
-8.9%
|
76,16
|
1.554.794
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
1.692
-0.7%
76,16
128.862
USD
|
1.692
-0.7%
|
76,16
|
128.862
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
3.528
-1.5%
76,16
268.690
USD
|
3.528
-1.5%
|
76,16
|
268.690
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
16.909
-11.9%
76,16
1.287.779
USD
|
16.909
-11.9%
|
76,16
|
1.287.779
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
2.942
-2.0%
76,16
224.061
USD
|
2.942
-2.0%
|
76,16
|
224.061
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
1.570
-1.1%
76,16
119.570
USD
|
1.570
-1.1%
|
76,16
|
119.570
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
593
-0.9%
76,16
45.163
USD
|
593
-0.9%
|
76,16
|
45.163
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
775
-0.8%
76,16
59.024
USD
|
775
-0.8%
|
76,16
|
59.024
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
4.730
-4.4%
76,16
360.234
USD
|
4.730
-4.4%
|
76,16
|
360.234
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
888
-1.4%
76,16
67.630
USD
|
888
-1.4%
|
76,16
|
67.630
USD
|
|
2023-03-07 |
2023-03-03 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
4.403
-6.5%
76,16
335.330
USD
|
4.403
-6.5%
|
76,16
|
335.330
USD
|
|
2023-03-06 |
2023-03-03 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
2.059
-2.9%
77,64
159.859
USD
|
2.059
-2.9%
|
77,64
|
159.859
USD
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
281
-0.4%
75,28
21.153
USD
|
281
-0.4%
|
75,28
|
21.153
USD
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
1.213
-0.7%
75,28
91.312
USD
|
1.213
-0.7%
|
75,28
|
91.312
USD
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
1.055
-1.1%
75,28
79.418
USD
|
1.055
-1.1%
|
75,28
|
79.418
USD
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
937
-0.9%
75,28
70.535
USD
|
937
-0.9%
|
75,28
|
70.535
USD
|
|
2023-03-06 |
2023-03-02 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
844
-1.4%
75,28
63.535
USD
|
844
-1.4%
|
75,28
|
63.535
USD
|
|
2023-03-03 |
2023-03-02 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
308
-0.5%
76,05
23.424
USD
|
308
-0.5%
|
76,05
|
23.424
USD
|
|
2023-03-03 |
2023-03-02 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
3.799
-6.0%
75,32
286.154
USD
|
3.799
-6.0%
|
75,32
|
286.154
USD
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
2.164
-1.2%
76,36
165.248
USD
|
2.164
-1.2%
|
76,36
|
165.248
USD
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
1.684
-2.6%
76,36
128.594
USD
|
1.684
-2.6%
|
76,36
|
128.594
USD
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Shah Pritesh
Chief Growth Officer
Führungsperson
|
1.923
-1.9%
76,36
146.845
USD
|
1.923
-1.9%
|
76,36
|
146.845
USD
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
2.198
-2.2%
76,36
167.845
USD
|
2.198
-2.2%
|
76,36
|
167.845
USD
|
|
2023-03-02 |
2023-03-01 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
755
-1.1%
76,36
57.654
USD
|
755
-1.1%
|
76,36
|
57.654
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.183
-13.5%
120,00
861.960
USD
|
7.183
-13.5%
|
120,00
|
861.960
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.183
-13.5%
114,00
818.863
USD
|
7.183
-13.5%
|
114,00
|
818.863
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
5.517
-10.7%
108,00
595.836
USD
|
5.517
-10.7%
|
108,00
|
595.836
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.500
-14.0%
108,00
810.000
USD
|
7.500
-14.0%
|
108,00
|
810.000
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
7.826
-14.5%
108,00
845.208
USD
|
7.826
-14.5%
|
108,00
|
845.208
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
1.010
-2.1%
117,00
118.170
USD
|
1.010
-2.1%
|
117,00
|
118.170
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
526
-1.1%
115,03
60.508
USD
|
526
-1.1%
|
115,03
|
60.508
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
417
-0.9%
108,00
45.036
USD
|
417
-0.9%
|
108,00
|
45.036
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
2.345
-4.6%
119,01
279.073
USD
|
2.345
-4.6%
|
119,01
|
279.073
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Weinberg Uri
Chief Science Officer
Führungsperson
|
1.201
-2.7%
120,00
144.120
USD
|
1.201
-2.7%
|
120,00
|
144.120
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Weinberg Uri
Chief Science Officer
Führungsperson
|
2.617
-5.6%
108,00
282.636
USD
|
2.617
-5.6%
|
108,00
|
282.636
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Weinberg Uri
Chief Science Officer
Führungsperson
|
1.946
-4.0%
120,00
233.520
USD
|
1.946
-4.0%
|
120,00
|
233.520
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Weinberg Uri
Chief Science Officer
Führungsperson
|
2.379
-4.8%
120,00
285.480
USD
|
2.379
-4.8%
|
120,00
|
285.480
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
187.500
-93.2%
108,00
20.250.000
USD
|
187.500
-93.2%
|
108,00
|
20.250.000
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
500
-3.6%
119,99
59.994
USD
|
500
-3.6%
|
119,99
|
59.994
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.344
-8.7%
119,35
160.405
USD
|
1.344
-8.7%
|
119,35
|
160.405
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.123
-12.1%
118,47
251.515
USD
|
2.123
-12.1%
|
118,47
|
251.515
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
999
-5.4%
117,01
116.894
USD
|
999
-5.4%
|
117,01
|
116.894
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.395
-7.0%
116,06
161.906
USD
|
1.395
-7.0%
|
116,06
|
161.906
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
3.702
-15.7%
115,21
426.512
USD
|
3.702
-15.7%
|
115,21
|
426.512
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
4.568
-16.2%
114,35
522.362
USD
|
4.568
-16.2%
|
114,35
|
522.362
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.000
-6.6%
112,86
225.726
USD
|
2.000
-6.6%
|
112,86
|
225.726
USD
|
|
2023-01-09 |
2023-01-05 |
GV
Geplanter Verkauf
|
Danziger Asaf
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
8.369
-21.7%
111,23
930.916
USD
|
8.369
-21.7%
|
111,23
|
930.916
USD
|
|
2023-01-09 |
2023-01-05 |
V
Verkauf
|
Shah Pritesh
Chief Commercial Officer
Führungsperson
|
387
-0.5%
108,00
41.796
USD
|
387
-0.5%
|
108,00
|
41.796
USD
|
|
2022-10-17 |
2022-10-13 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
6.754
-13.4%
76,01
513.372
USD
|
6.754
-13.4%
|
76,01
|
513.372
USD
|
|
2022-10-07 |
2022-10-06 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
6.754
-11.8%
84,37
569.835
USD
|
6.754
-11.8%
|
84,37
|
569.835
USD
|
|
2022-09-26 |
2022-09-22 |
V
Verkauf
|
Leonard Frank X
President, CNS Cancers US
Führungsperson
|
6.754
-9.6%
77,00
520.058
USD
|
6.754
-9.6%
|
77,00
|
520.058
USD
|
|
2022-09-19 |
2022-09-15 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
5.517
-7.2%
90,00
496.530
USD
|
5.517
-7.2%
|
90,00
|
496.530
USD
|
|
2022-09-19 |
2022-09-15 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
6.754
-8.1%
87,31
589.692
USD
|
6.754
-8.1%
|
87,31
|
589.692
USD
|
|
2022-09-12 |
2022-09-09 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
1.863
-2.2%
88,00
163.944
USD
|
1.863
-2.2%
|
88,00
|
163.944
USD
|
|
2022-09-07 |
2022-09-06 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
1.384
-1.6%
78,57
108.741
USD
|
1.384
-1.6%
|
78,57
|
108.741
USD
|
|
2022-09-06 |
2022-09-02 |
V
Verkauf
|
Shah Pritesh
Chief Commercial Officer
Führungsperson
|
269
-0.3%
79,04
21.261
USD
|
269
-0.3%
|
79,04
|
21.261
USD
|
|
2022-09-06 |
2022-09-02 |
V
Verkauf
|
Burke William Patrick
Chief Human Resources Officer
Führungsperson
|
718
-1.3%
79,04
56.749
USD
|
718
-1.3%
|
79,04
|
56.749
USD
|
|
2022-09-06 |
2022-09-02 |
V
Verkauf
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Führungsperson
|
296
-0.2%
79,04
23.395
USD
|
296
-0.2%
|
79,04
|
23.395
USD
|
|
2022-09-06 |
2022-09-02 |
V
Verkauf
|
Cordova Ashley
Chief Financial Officer
Führungsperson
|
885
-1.2%
79,04
69.948
USD
|
885
-1.2%
|
79,04
|
69.948
USD
|
|
2022-09-06 |
2022-09-02 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
584
-0.7%
79,04
46.158
USD
|
584
-0.7%
|
79,04
|
46.158
USD
|
|
2022-09-06 |
2022-09-01 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
48
-0.1%
78,96
3.790
USD
|
48
-0.1%
|
78,96
|
3.790
USD
|
|
2022-09-06 |
2022-09-01 |
V
Verkauf
|
Leonard Frank X
Chief Development Officer
Führungsperson
|
438
-0.5%
78,14
34.225
USD
|
438
-0.5%
|
78,14
|
34.225
USD
|
|